Response of pups with maternal derived antibody to modified-live canine parvovirus vaccine

C Buonavoglia; M Tollis; D Buonavoglia; A Puccini

doi:10.1016/0147-9571(92)90007-e

Response of pups with maternal derived antibody to modified-live canine parvovirus vaccine

Comp Immunol Microbiol Infect Dis. 1992 Oct;15(4):281-3. doi: 10.1016/0147-9571(92)90007-e.

Authors

C Buonavoglia¹, M Tollis, D Buonavoglia, A Puccini

Affiliation

¹ Istituto di Malattie infettive e parassitarie degli animali domestici, Facoltà di Medicina Veterinaria, Università degli Studi di Bari, Italy.

PMID: 1330425
DOI: 10.1016/0147-9571(92)90007-e

Abstract

The AA reports the results of vaccination against canine parvovirus (CPV) of pups with maternal antibody, utilizing a modified-live virus (MLV) CPV vaccine having a titer of 10(7) TCID50/dose. This vaccine was shown to be effective also when HI antibody titers of pups were < or = 1:80.

MeSH terms

Animals
Animals, Newborn
Antibodies, Viral / biosynthesis
Antibodies, Viral / immunology
Dog Diseases / immunology
Dog Diseases / microbiology
Dog Diseases / prevention & control*
Dogs
Immunity, Maternally-Acquired*
Parvoviridae / immunology*
Parvoviridae Infections / immunology
Parvoviridae Infections / prevention & control
Parvoviridae Infections / veterinary*
Vaccination / veterinary
Viral Vaccines / administration & dosage*
Viral Vaccines / immunology

Substances

Antibodies, Viral
Viral Vaccines